Sort   by:  
 Page size 
Unknown"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?
Not available
S-EPMC10053373 | biostudies-literature
Unknownp65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.
Not available
S-EPMC6570906 | biostudies-literature
Unknownp65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors.
Not available
S-EPMC8215537 | biostudies-literature
UnknownVav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.
Not available
S-EPMC5980196 | biostudies-literature
UnknownGSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis.
Not available
S-EPMC4077702 | biostudies-literature
UnknownIn triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.
Not available
S-EPMC3866498 | biostudies-literature
UnknownUnexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients.
Not available
S-EPMC5097093 | biostudies-literature
UnknownEctopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
Not available
S-EPMC6590318 | biostudies-literature
UnknownA Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer.
Not available
S-EPMC9818547 | biostudies-literature
UnknownHigh nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Not available
S-EPMC4147326 | biostudies-literature
Sort   by:  
 Page size